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Identity 
Other names: Malignant tumors of the central nervous 
system associated with familial polyposis of the colon. 
Note: Turcot syndrome (TS) is characterized by the 
association of colonic polyps and central nervous 
system tumors. The relative risk of cerebral tumor in 
patients with familial adenomatous polyposis is 
considered 92 times more that found in the general 
population. The predominant brain tumors are 
medulloblastoma and gliomas. 
Inheritance: Both autosomal dominant and autosomal 
recessive modes of inheritance have been described, 
based on the analysis of familial segregation of the
disease and the results of molecular studies. 
Nevertheless, considering the low penetrance and rarity
of TS, the involvement of a major gene in association 
with a second locus containing a modifier gene or of 
environmenmtal factors has been suggested. 
Clinics 
Neoplastic risk 
Cardinal findings in TS are colonic polyps with 
tendency to colorectal cancer and malignant central 
nervous system tumors. 
Colonic polyps: Three types of polyposis coli are 
described to occur in TS: 1) Type 1 is characterized by 
multiple colonic polyps numbering between 20 and 
100, some of which may exceed 3 cm in diameter; 2) 
Type 2 is characterizd by a small number of colonic 
polyps, usually less than 10; 3) Type 3 is characteized 
by numerous small colonic polyps similar to those of 
classical familial polyposys coli. Based on molecular 
entities, two groups can differentiated: the one duto 
mutation in the APC gene (see below), characterized by 
colonic polyps, the second one due to mutations in the 
DNA mismatch repair (MMR) genes (see below) and 
characterized by colorectal adenomas without 
polyposis. 
Colorectal cancer: the polyps frequently show 
malignant transformation in the second and third 
decades of life. 
Central nervous system tumors: Two major types of TS 
are distinguished based on different types of central 
nervous system tumors. The first one is characterized 
by childhood cerebellar medullobastoma and the 
second by gliomas, particularly glioblastoma 
multiforme, arising in both children and adult. The two 
different types are related to different molecular 
pathogenesis. In fact, the first type is caused by 
mutations in the APC gene (see below), whereas the 
second type is related to MMR genes mutations (see 
below). 
Other: In some instances, patients with TS have 
additional symptoms characteristic of other genetic 
conditions with familial polyposis of the coli, including 
pigmented ocular fundus lesions, epidermal inclusion 
cysts, osteosclerotic jaw lesions, cafe-au-lait spots or 
lipomas. 
Cytogenetics 
Note: Chromosome analysis is generally normal in 
patients with TS 
Genes involved and Proteins 
APC (Adenomatous Popyposis of the 
Colon) 
Location: 5q21 
Note: The APC locus consists of 15 exons. 
Protein 
Function: APC: APC seems to be invoved in cell 
adhesion with a role in the beta-catenin -APC 
interaction. It is possible that the APC complex  
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regulates transmission of the contact inhibition signal 
into the cells, since APC mutations are associated with 
the development of hyperplasia, an early event in 
tumorigenesis. Alternatively, it is possible that the 
APC-catenin complex regulates adhesions, since loss of 
cadherin-mediated adhesion can contribute to 
metastasis 
Mutations 
Germline APC mutations are detectable in 2/3 of 
patients with TS. In the remaining patients, germline 
mutations in MMR genes can be found. Molecular 
analysis have shown that heterozygous, homozygous or 
compound heterozygous mutations may be implicated 
in TS. TS caused by APC mutations is associated with 
childhood cerebellar medulloblastoma and colonic 
polyps, while TS related to MMR genes is associated 
with glioma and colorectal adenomas without 
polyposis. Nevertheless, there is a wide clinical 
heterogeneity among carriers of mutations in the same 
gene, and even among pedigrees segregating for the 
same molecular defect. Such variations could be 
accounted for by genetic or environmental modifiers.  
MLH1 
Location: 3p21.3 
Note: The MLH1 locus encompasses approximately 
100 kb and consists of 19 exons. 
Protein 
Function: MMR genes: MLH1 and PMS2 are involved 
in DNA mismatch repair, and neoplasms of affected 
patients show DNA replication errros. 
PMS2 
Location: 7p22 
Note: The PMS2 locus encompasses 16 kb and consists 
of 15 exons 
Mutations 
PMS2 mutations have been identified in a few families 
so far, and a very severe phenotype has been describ d 
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